Research Archives

September 27, 2017 Award honors Parkinson’s pioneer

GRAND RAPIDS, Mich. (Sept. 27, 2017) — Van Andel Research Institute and The Cure Parkinson’s Trust announce Thomas Foltynie, B.Sc., MBBS, MRCP,…

September 25, 2017 Van Andel Research Institute hosts unique symposium on Parkinson’s disease

Grand Rapids, Mich. (Sept. 25, 2017)—Leading Parkinson’s experts and advocates from around the world will gather at Van Andel Research Institute in…

September 20, 2017 $2.375 million federal award to study epigenetic control systems, inform drug discovery

GRAND RAPIDS, MI (Sept. 20, 2017)—Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing…

March 28, 2017 Van Andel Research Institute installs world-class microscopes to enable discovery of the molecular basis of disease

GRAND RAPIDS, Mich. (March 28, 2017)—Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building…

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

February 21, 2017 ORC as Loader of the Rings: Study details ringed structure of ORC in DNA replication

GRAND RAPIDS, Mich. (Feb. 21, 2017)—An international collaboration of life scientists, including experts at Van Andel Research Institute, has described in exquisite detail the…

September 8, 2016 Diabetes drug focus of new clinical trial for Parkinson’s disease

HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…

September 7, 2016 The whole of epigenetic regulation may be greater than the sum of its parts

GRAND RAPIDS, Mich. (September 7, 2016)—Scientists may be closer to answering a long-standing question in biology—how do the components of cells’ molecular machinery work together…